RECRUITING

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

Official Title

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Quick Facts

Study Start:2023-08-28
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05868902

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Willing to provide informed consent
  2. * Male or female, aged 40 and up (inclusive) at the time of enrollment
  3. * Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
  4. * Completed cardiac PET within 2 weeks prior to study enrollment
  1. * Patients unable to fit into CardioFlux device.
  2. * Patients unable to lie supine for 5 minutes.
  3. * Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
  4. * Ongoing atrial fibrillation or atrial flutter
  5. * Life expectancy \<1 yrs. due to non-cardiovascular comorbidity

Contacts and Locations

Study Contact

Zoe E Swann, PhD
CONTACT
4802868695
zoe.swann@genetesis.com
Robert Takla, MD
CONTACT
robert.takla@genetesis.com

Study Locations (Sites)

Cleveland Clinic
Cleveland, Ohio, 44195
United States
Kettering Health
Kettering, Ohio, 45429
United States

Collaborators and Investigators

Sponsor: Genetesis Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-28
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2023-08-28
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Magnetocardiography
  • Coronary Ischemia

Additional Relevant MeSH Terms

  • Coronary; Ischemic